Skip to content

Calcium hydroxide as a root canal treatment material to anterior primary teeth.

Calcium hydroxide as a filler material in pulpectomies of anterior primary teeth - Randomized clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-8287pp
Enrollment
Unknown
Registered
2017-07-18
Start date
2016-12-13
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periapical dental lesions with endodontic origin

Interventions

The study will include 120 children between 2 and 6 years of age, with need for endodontic treatment of anterior primary teeth. The groups will be defined after opening of brown envelopes, previously
Drug
Procedure/surgery

Sponsors

Universidade Federal de Santa Maria
Lead Sponsor
Universidade Federal de Santa Maria
Collaborator

Eligibility

Age
2 Years to 6 Years

Inclusion criteria

Inclusion criteria: Upper anterior primary teeth; Radiographic alteration suggestive of periapical lesion; Cavity that allows restorative recovery; Without any previous pulp treatment; Good systemic health.

Exclusion criteria

Exclusion criteria: Root resorption with more than 2/3; Radiographic rupture of the pericoronary sac of the permanent successor; Syndromes; Systemic changes

Design outcomes

Primary

MeasureTime frame
Remission of periaícal lesion through radiographic evaluation. Periapical lesions are classified among 4 possible scores. After comparing the final radiographs with the initial ones, it will be considered a success when there is reduction of the aspects of the lesion and decrease of the scores.

Secondary

MeasureTime frame
Remission of clinical signs, such as the presence of pain, mobility, fistula or edema. It will be considered clinical success when the element does not show these signs.

Countries

Brazil

Contacts

Public ContactLisara Pinto

Universidade Federal de Santa Maria

lis_tosatto@hotmail.com55 55 999145155

Outcome results

None listed

Source: REBEC (via WHO ICTRP)